Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are
needed to support clinical diagnosis and epidemiological investigations. Recently, assays …

Comment www. thelancet. com Vol 397 February 13, 2021 563 20% of the vaccine needs of
participating countries. 4 Most low-income and middle-income countries (LMICs) face …

Summary Background Coronavirus disease 2019 (COVID-19) is a disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in …

The current practice for diagnosis of SARS-CoV-2 infection relies on PCR testing of
nasopharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic …

Given the emergence of novel SARS-CoV-2 variants of concern, the performance of
available diagnostics for these new variants should be investigated. SARS-CoV-2 antigen …

The ongoing coronavirus disease 2019 (COVID-19) pandemic is a substantial challenge for
health-care systems and their infrastructure. RT-PCR-based diagnostic confirmation of …

Resolving the COVID-19 pandemic requires diagnostic testing to determine which
individuals are infected and which are not. The current gold standard is to perform RT-PCR …

There is a plethora of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)
serological tests based either on nucleocapsid phosphoprotein (N), S1-subunit of spike …

Background Our understanding of the global scale of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data …

For the first time in the post-war history of epidemics, there is a reversal of which countries
are most heavily affected by a disease pandemic. By early May, 2020, more than 90% of all …